Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002318743 | SCV000850088 | pathogenic | Inborn genetic diseases | 2016-07-08 | criteria provided, single submitter | clinical testing | The p.Y652* pathogenic mutation (also known as c.1956C>A), located in coding exon 7 of the ZEB2 gene, results from a C to A substitution at nucleotide position 1956. This changes the amino acid from a tyrosine to a stop codon within coding exon 7. This mutation has been described in a 35-week stillborn male fetus with features consistent with Mowat-Wilson syndrome, including dysmorphic facial features, hypospadias, ventricular septal defect, short corpus callosum, and Hirschsprung disease (Spaggiari E et al. Eur J Med Genet, 2013 Jun;56:297-300). A different nucleotide substitution at the same nucleotide position (c.1956C>G), also resulting in the p.Y652* nonsense mutation, was described in a 19-year-old Indonesian male with Mowat-Wilson syndrome, whose features included severe intellectual disability, hypotonia, onset of seizures at age 2 years, repetitive hand movements, and facial dysmorphism (Mundhofir FE et al. Case Rep Genet, 2012 Dec;2012:949507). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Genetic Services Laboratory, |
RCV000721184 | SCV000852177 | pathogenic | Mowat-Wilson syndrome | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000721184 | SCV002045646 | pathogenic | Mowat-Wilson syndrome | 2021-11-07 | criteria provided, single submitter | clinical testing |